88 related articles for article (PubMed ID: 19403391)
1. [Clinical features of interstitial pneumonitis due to interferon alpha therapy for chronic hepatitis C].
Ji FP; Li ZX; Deng H; Xue HA; Liu Y; Li M
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Apr; 29(4):667-70. PubMed ID: 19403391
[TBL] [Abstract][Full Text] [Related]
2. Interstitial pneumonitis during combination therapy with interferon-alpha and ribavirin in a patient with chronic Hepatitis C.
Rothfuss KS; Bode JC
Z Gastroenterol; 2002 Sep; 40(9):807-10. PubMed ID: 12215950
[TBL] [Abstract][Full Text] [Related]
3. Interstitial pneumonitis associated with pegylated interferon alpha-2b therapy for chronic hepatitis C: case report.
Carrillo-Esper R; González-Avila D; Uribe-Ríos M; Méndez-Sánchez N
Ann Hepatol; 2008; 7(1):87-90. PubMed ID: 18376374
[TBL] [Abstract][Full Text] [Related]
4. Interstitial pneumonitis after combination therapy with pegylated interferon alpha-2b and ribavirin for chronic hepatitis C.
Chen YC; Lu SN; Lin MC
Chang Gung Med J; 2007; 30(1):92-7. PubMed ID: 17477035
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and management of interstitial pneumonitis associated with interferon therapy for chronic hepatitis C.
Ji FP; Li ZX; Deng H; Xue HA; Liu Y; Li M
World J Gastroenterol; 2010 Sep; 16(35):4394-9. PubMed ID: 20845505
[TBL] [Abstract][Full Text] [Related]
6. [Pulmonary toxicity by pegylated interferon alpha-2a in a patient with chronic hepatitis C].
Son BK; Sohn JH; Kim TY; Park YK; Jeon YC; Han DS
Korean J Hepatol; 2007 Mar; 13(1):103-7. PubMed ID: 17380081
[TBL] [Abstract][Full Text] [Related]
7. Interstitial pneumonitis in a patient with chronic hepatitis C and chronic renal failure on interferon therapy.
Kang EJ; Kim DK; Jeon SR; Choi HS; Jeong SW; Jang JY; Lee JS; Uh ST
Korean J Gastroenterol; 2011 Jul; 58(1):47-52. PubMed ID: 21778804
[TBL] [Abstract][Full Text] [Related]
8. Development of sarcoidosis during interferon alpha 2b and ribavirin combination therapy for chronic hepatitis C--a case report and review of the literature.
Bolukbas C; Bolukbas FF; Kebdir T; Canayaz L; Dalay AR; Kilic G; Ovunc O
Acta Gastroenterol Belg; 2005; 68(4):432-4. PubMed ID: 16432996
[TBL] [Abstract][Full Text] [Related]
9. Pegylated-interferon induced interstitial pneumonitis.
Nomani AZ; Qureshi MS; Barki UF; Wazir M; Kashmir SB; Nomani H
J Coll Physicians Surg Pak; 2014 Mar; 24(3):219-20. PubMed ID: 24613125
[No Abstract] [Full Text] [Related]
10. Pleural effusion associated with pegylated interferon alpha and ribavirin treatment for chronic hepatitis C.
Arora A; Vargas L; Kuzniar TJ
J Hosp Med; 2009 Sep; 4(7):E45-6. PubMed ID: 19753589
[TBL] [Abstract][Full Text] [Related]
11. Interstitial pneumonia recurrence during chronic hepatitis C treatment.
Renou C; Germain S; Harafa A; Martin S; Larroque O; Muller P; Bertrand JJ; Halfon P
Am J Gastroenterol; 2005 Jul; 100(7):1625-6. PubMed ID: 15984999
[No Abstract] [Full Text] [Related]
12. Interstitial pneumonitis in a patient treated with alpha-interferon and ribavirin for hepatitis C infection.
Karim A; Ahmed S; Khan A; Steinberg H; Mattana J
Am J Med Sci; 2001 Oct; 322(4):233-5. PubMed ID: 11678522
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary complications associated with pegylated interferon and ribavirin in HIV/hepatitis C virus coinfected patients.
Vasilij Benatti S; Giampaolo Q; Sara B; Marco R; Diego R
AIDS; 2014 Nov; 28(17):2633-5. PubMed ID: 25574965
[No Abstract] [Full Text] [Related]
14. [Induced interstitial pneumonitis: role of pegylated interferon alpha 2b].
Rocca P; Dumortier J; Tanière P; Duperret S; Vial T; Cottin V; Delafosse B; Scoazec JY; Boillot O
Gastroenterol Clin Biol; 2002 Apr; 26(4):405-8. PubMed ID: 12070414
[TBL] [Abstract][Full Text] [Related]
15. [Pulmonal sarcoidosis: A rare side effect of interferon-alpha treatment for chronic hepatitis C infection].
Pohl J; Stremmel W; Kallinowski B
Z Gastroenterol; 2000 Dec; 38(12):951-5. PubMed ID: 11194885
[TBL] [Abstract][Full Text] [Related]
16. Comparison of a 6-month course peginterferon alpha-2b plus ribavirin and interferon alpha-2b plus ribavirin in treating Chinese patients with chronic hepatitis C in Taiwan.
Lee SD; Yu ML; Cheng PN; Lai MY; Chao YC; Hwang SJ; Chang WY; Chang TT; Hsieh TY; Liu CJ; Chen DS
J Viral Hepat; 2005 May; 12(3):283-91. PubMed ID: 15850469
[TBL] [Abstract][Full Text] [Related]
17. A randomized controlled trial of pegylated interferon alpha-2a (40 KD) or interferon alpha-2a plus ribavirin and amantadine vs interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C.
Mangia A; Ricci GL; Persico M; Minerva N; Carretta V; Bacca D; Cela M; Piattelli M; Annese M; Maio G; Conte D; Guadagnino V; Pazienza V; Festi D; Spirito F; Andriulli A
J Viral Hepat; 2005 May; 12(3):292-9. PubMed ID: 15850470
[TBL] [Abstract][Full Text] [Related]
18. Chronic hepatitis C genotype 6 responds better to pegylated interferon and ribavirin combination therapy than genotype 1.
Tsang OT; Zee JS; Chan JM; Li RS; Kan YM; Li FT; Lo FH; Chow DA; Cheung KW; Chan KH; Yeung YW; Ng FH; Li MK; Kwan WK; Lai TS
J Gastroenterol Hepatol; 2010 Apr; 25(4):766-71. PubMed ID: 20492332
[TBL] [Abstract][Full Text] [Related]
19. Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.
Chen TM; Huang PT; Tsai MH; Lin LF; Liu CC; Ho KS; Siauw CP; Chao PL; Tung JN
J Gastroenterol Hepatol; 2007 May; 22(5):669-75. PubMed ID: 17444854
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of early virological response to treatment with different interferon-based regimens plus ribavirin in patients with chronic hepatitis C.
Napoli N; Giannelli G; Parisi CV; Antonaci A; Maddalena G; Antonaci S
New Microbiol; 2005 Jan; 28(1):13-21. PubMed ID: 15782622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]